QualityStocks

[QualityStocks]

CD International Enterprises, Inc. (CDII) Launches Green Products Distribution Subsidiary

CD International Enterprises, Inc. (OTC: CDII), a U.S.-based company that sources industrial commodities and provides business and management corporate consulting services, this morning announced the launch of wholly-owned subsidiary Green Products Distribution, Inc. and its associated online store (http://www.greencbdproducts.com/cbd). The announcement comes as part of CDII’s ongoing expansion initiative, which centers on the bulk distribution of cannabidiol (CBD) crystal in the U.S. and the sale of a collection of CBD-based products in various Chinese-speaking communities located around the globe.

Per this morning’s news release, CDII expects to bring the newly-announced Green Products Distribution online store to fully functioning status within the next several weeks. Following this milestone, the company intends to contract an online marketing firm in an effort to market both the store and its CBD-based products in a number of Chinese-speaking communities, which, combined, represent a global market of more than two billion people. In addition to the continued refinement of the new website, CDII also intends to develop a mobile app in order to facilitate optimal distribution of its CBD-based products through increasingly popular mobile commerce channels.

“We are very excited to begin retailing CBD-based products in Chinese-speaking communities through the newly established subsidiary, while also pursuing opportunities to distribute bulk CBD crystal in the U.S.,” Dr. James Wang, chairman and CEO of CDII, stated in this morning’s news release. “Research has indicated CBD to be effective in treating epilepsy, Alzheimer’s disease, cirrhosis of the liver and to provide relief from hangover, anxiety and stress. Because natural extract of CBD-based products is so similar to traditional Chinese medicine, management believes there is huge opportunity in Chinese-speaking communities for CBD-based products.”

In support of its newly-launched subsidiary, CDII is actively sourcing a variety of CBD-based products in the U.S., with initial plans in place to enter several distribution agreements in the near term. Through these planned agreements, CDII will also look to commercialize its products through retail pharmacies and Chinese medicine stores across Mainland China.

This morning’s update comes less than two weeks after CDII announced its entry into a multi-year distribution agreement with Zhangjianjie Shengshi Agricultural Development Company, Ltd. to distribute high-grade CBD crystal in the United States. According to data published by The Hemp Business Journal, CBD is currently one of the fastest-growing market categories in the U.S. hemp and legal marijuana industries, boasting a compound annual growth rate of roughly 59 percent. The CBD industry accounted for $202 million in consumer sales in 2015, and forecasts call for that figure to grow to about $2.1 billion by 2020.

For more information, visit the company’s website at www.CDII.net